Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-10-21
2009-06-09
Aulakh, Charanjit S (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S018000
Reexamination Certificate
active
07544693
ABSTRACT:
Compounds of formula I:wherein Ar is a moiety of formula II or III:and pharmaceutically-acceptable salts thereof, wherein A, B, and R1are as defined in the specification, enantiomers, in vivo-hydrolysable precursors, pharmaceutical compositions and formulations containing them, methods of using them to treat diseases and conditions either alone or in combination with other therapeutically-active compounds or substances, processes and intermediates used to prepare them and uses of them for diagnostic and analytic purposes.
REFERENCES:
patent: 00/42044 (2000-07-01), None
patent: 02/096912 (2002-12-01), None
patent: 03/087102 (2003-10-01), None
patent: 03/087103 (2003-10-01), None
AstraZeneca AB
Aulakh Charanjit S
Mitchell Kenneth F.
LandOfFree
Spirofuropyridine aryl derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spirofuropyridine aryl derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spirofuropyridine aryl derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4108772